blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2809670

EP2809670 - 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AND THEIR USE AS KINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.03.2018
Database last updated on 19.07.2024
FormerThe patent has been granted
Status updated on  14.04.2017
FormerGrant of patent is intended
Status updated on  19.12.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Vernalis (R&D) Limited
100 Berkshire Place, Wharfdale Road
Winnersh
Berkshire RG41 5RD / GB
[2017/03]
Former [2014/50]For all designated states
Vernalis (R&D) Limited
100 Berkshire Place
Wharfdale Road
Winnersh
Berkshire RG41 5RD / GB
Inventor(s)01 / STOKES, Stephen
c/o Vernalis (R&D) Limited
100 Berkshire Place
Wharfdale Road
Winnersh, Berkshire RG41 5RD / GB
02 / GRAHAM, Christoper John
c/o Vernalis (R&D) Limited
100 Berkshire Place
Wharfdale Road
Winnersh, Berkshire RG41 5RD / GB
03 / RAY, Stuart Christopher
c/o Vernalis (R&D) Limited
100 Berkshire Place
Wharfdale Road
Winnersh, Berkshire RG41 5RD / GB
04 / STEFANIAK, Emma Jayne
c/o Vernalis (R&D) Limited
100 Berkshire Place
Wharfdale Road
Winnersh, Berkshire RG41 5RD / GB
 [2014/50]
Representative(s)Gill Jennings & Every LLP
The Broadgate Tower
20 Primrose Street
London EC2A 2ES / GB
[2017/20]
Former [2014/50]Stevens, Fiona
Gill Jennings & Every LLP The Broadgate Tower
20 Primrose Street
London EC2A 2ES / GB
Application number, filing date13703121.730.01.2013
[2017/20]
WO2013GB50212
Priority number, dateGB2012000156630.01.2012         Original published format: GB 201201566
[2014/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013114113
Date:08.08.2013
Language:EN
[2013/32]
Type: A1 Application with search report 
No.:EP2809670
Date:10.12.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 08.08.2013 takes the place of the publication of the European patent application.
[2014/50]
Type: B1 Patent specification 
No.:EP2809670
Date:17.05.2017
Language:EN
[2017/20]
Search report(s)International search report - published on:EP08.08.2013
ClassificationIPC:C07D471/04, A61K31/437, A61K31/496, A61P35/00, A61P37/00
[2014/50]
CPC:
C07D471/04 (EP,CN,US); A61K31/437 (EP,US); A61K31/4545 (EP,US);
A61K45/06 (EP,US); A61P17/00 (EP); A61P19/02 (EP);
A61P25/00 (EP); A61P29/00 (EP); A61P35/00 (EP);
A61P37/00 (EP); A61P37/06 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/437, A61K2300/00 (US,EP);
A61K31/4545, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/50]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:1H-PYRROLO-[2,3-B-]PYRIDINDERIVATE UND DEREN VERWENDUNG ALS KINASEHEMMER[2014/50]
English:1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AND THEIR USE AS KINASE INHIBITORS[2014/50]
French:DÉRIVÉS DE 1H-PYRROLO[2,3-B]PYRIDINE ET LEUR UTILISATION COMME INHIBITEURS DE KINASES[2014/50]
Entry into regional phase08.08.2014National basic fee paid 
08.08.2014Designation fee(s) paid 
08.08.2014Examination fee paid 
Examination procedure22.11.2013Request for preliminary examination filed
International Preliminary Examining Authority: EP
08.08.2014Amendment by applicant (claims and/or description)
08.08.2014Examination requested  [2014/50]
15.04.2016Despatch of a communication from the examining division (Time limit: M04)
16.08.2016Reply to a communication from the examining division
20.12.2016Communication of intention to grant the patent
04.04.2017Fee for grant paid
04.04.2017Fee for publishing/printing paid
04.04.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.04.2016
Opposition(s)20.02.2018No opposition filed within time limit [2018/17]
Fees paidRenewal fee
13.01.2015Renewal fee patent year 03
11.01.2016Renewal fee patent year 04
11.01.2017Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL17.05.2017
CY17.05.2017
EE17.05.2017
HR17.05.2017
LT17.05.2017
LV17.05.2017
MC17.05.2017
MK17.05.2017
RS17.05.2017
SI17.05.2017
SK17.05.2017
SM17.05.2017
BG17.08.2017
NO17.08.2017
IS17.09.2017
LU30.01.2018
MT30.01.2018
[2020/34]
Former [2020/31]CY17.05.2017
EE17.05.2017
HR17.05.2017
LT17.05.2017
LV17.05.2017
MC17.05.2017
MK17.05.2017
RS17.05.2017
SI17.05.2017
SK17.05.2017
SM17.05.2017
BG17.08.2017
NO17.08.2017
IS17.09.2017
LU30.01.2018
MT30.01.2018
Former [2020/08]EE17.05.2017
HR17.05.2017
LT17.05.2017
LV17.05.2017
MC17.05.2017
RS17.05.2017
SI17.05.2017
SK17.05.2017
SM17.05.2017
BG17.08.2017
NO17.08.2017
IS17.09.2017
LU30.01.2018
MT30.01.2018
Former [2019/30]EE17.05.2017
HR17.05.2017
LT17.05.2017
LV17.05.2017
MC17.05.2017
RS17.05.2017
SI17.05.2017
SK17.05.2017
SM17.05.2017
BG17.08.2017
NO17.08.2017
IS17.09.2017
LU30.01.2018
Former [2018/47]EE17.05.2017
HR17.05.2017
LT17.05.2017
LV17.05.2017
RS17.05.2017
SI17.05.2017
SK17.05.2017
SM17.05.2017
BG17.08.2017
NO17.08.2017
IS17.09.2017
LU30.01.2018
Former [2018/25]EE17.05.2017
HR17.05.2017
LT17.05.2017
LV17.05.2017
RS17.05.2017
SI17.05.2017
SK17.05.2017
SM17.05.2017
BG17.08.2017
NO17.08.2017
IS17.09.2017
Former [2018/11]EE17.05.2017
HR17.05.2017
LT17.05.2017
LV17.05.2017
RS17.05.2017
SK17.05.2017
SM17.05.2017
BG17.08.2017
NO17.08.2017
IS17.09.2017
Former [2018/09]EE17.05.2017
HR17.05.2017
LT17.05.2017
LV17.05.2017
RS17.05.2017
BG17.08.2017
NO17.08.2017
IS17.09.2017
Former [2017/52]HR17.05.2017
LT17.05.2017
LV17.05.2017
RS17.05.2017
BG17.08.2017
NO17.08.2017
IS17.09.2017
Former [2017/49]HR17.05.2017
LT17.05.2017
NO17.08.2017
IS17.09.2017
Cited inInternational search[ID]WO2009089352  (ARRAY BIOPHARMA INC [US], et al) [ID] 1-18 * abstract * * page 110; example 72 * * claims 1-64 *;
 [XDI]WO2009140320  (ARRAY BIOPHARMA INC [US], et al) [XD] 1-4,7-11,13,14 * abstract * * example 45 * * example 64 * * claims 1-61 * [I] 5,6,12,15-18;
 [A]WO2009151589  (GENENTECH INC [US], et al) [A] 1-18 * abstract * * pages 60-61; table 1 ** claims 1-35 *
by applicantWO2009089352
 WO2009140320
    - "Pro-drugs as Novel Delivery Systems", T. HIGUCHI; W. STELLA, Bioreversible Carriers in Drug Design, PERGAMON PRESS, (1987), vol. 14
    - J MARCH, Advanced organic chemistry, WILEY
    - R.C. LAROCK, Comprehensive Organic Transformation, WILEY
    - A.R. KATRITZKY, Handbook of Heterocyclic Chemistry, PERGAMON
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.